The first edition of the ENCANTO newsletter
We are proud to announce the release of the first edition of the ENCANTO newsletter, offering a look at the project’s vision and collaborative efforts for innovation in patellofemoral osteoarthritis (PFOA).
Highlights from this issue include:
- An introduction to N-TEC and its therapeutic potential
- Overview of clinical trial phases and objectives (2024–2029)
- Key findings from published clinical studies, including a pivotal paper in Science Translational Medicine
- Consortium spotlight and key events in Rome, Basel, and Dubrovnik
ENCANTO brings together 21 partners from 10 European countries and exemplifies the power of cross-border cooperation in advancing next-generation orthopaedic therapies.
Backed by the Horizon Europe programme, ENCANTO aims to shift the focus from symptom management to true tissue repair.
Read the full newsletter here.